Why is everyone so down on MP and Carisomes. Macro economic, reimbursement, and R/D challenges are expected for any business breaking new ground and especially for one positioning itself in a field that is revolutionizing the health industry. Every major pharmaceutical and Dx company has a program looking at microvesicles and exosomes. Yes that's right companies like Roche, Abbott, GE, Myriad, etc, etc even Samsung is looking into it, The NIH is funding deep translational research programs. Don't be so short sighted and petty, have a little patience and show some passion and vision or look for an old school lab service job where you'll be happy. You are lucky to be involved with such a forward looking organization.
Perhaps someone will followup with some rational dialogue instead of spewing the unprofessional and nonconstructive stuff that has been expressed so far.